Company Filing History:
Years Active: 2014-2016
Title: Martin M Conda-Sheridan: Innovator in Anticancer Research
Introduction
Martin M Conda-Sheridan is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of anticancer research, holding a total of three patents. His work focuses on the synthesis and use of innovative compounds that target specific enzymes involved in cancer progression.
Latest Patents
One of his latest patents involves the synthesis and use of dual tyrosyl-DNA phosphodiesterase I (Tdp1) and topoisomerase I (Top1) inhibitors. This invention pertains to certain N-substituted indenoisoquinoline compounds that inhibit the activity of Tdp1 or Top1, or both, demonstrating potential anticancer activity. The patent also discloses novel N-substituted indenoisoquinoline compounds and pharmaceutical compositions that include these innovative compounds.
Career Highlights
Martin M Conda-Sheridan is associated with the Purdue Research Foundation, where he continues to advance his research in the field of cancer therapeutics. His work has garnered attention for its potential impact on cancer treatment and drug development.
Collaborations
He has collaborated with notable colleagues such as Mark Stanley Cushman and Trung X Nguyen, contributing to the advancement of research in his field.
Conclusion
Martin M Conda-Sheridan is a prominent figure in the realm of anticancer research, with a focus on innovative compounds that hold promise for future therapies. His contributions through patents and collaborations highlight his commitment to advancing medical science.